Get started
Author

Natalie Ruggio

Observed name: N. Ruggio
ORCID: 0000-0002-9696-2233
Observed ORCID: 0000-0002-9696-2233
OpenAlex ID: A5032463457
Phosphatidylserine receptors enhance SARS-CoV-2 infection
2021 · Dana Bohan, Hanora Van Ert, et al. · PLoS Pathogens · 133
IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection
2019 · Kai J. Rogers, Bethany Brunton, et al. · PLoS neglected tropical diseases · 37
PDF
A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner
2021 · Nicholas J. Lennemann, Jacob Dillard, et al. · Journal of Virology · 4
Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein
2022 · Hanora A. Van Ert, Dana W. Bohan, et al. · Microbiology Spectrum · 3
DNA Aptamers for Early Detection of Ebolavirus
2021 · Soma Banerjee, Jan Hoinka, et al. · The FASEB Journal · 2
Challenges in HLA and ABO typing of deceased organ donors with prior hematopoietic stem cell transplantation: two cases and practical considerations for evaluation
2026 · Qingyong Xu, Kristen Stone, et al. · Human Immunology
Misbhaving cells – Deceased donor with Crohn’s disease showed complete depletion of circulating B cells
2024 · N. Ruggio, G. Barajas, et al. · Human Immunology
Abstract 3245: AXL as a therapeutic target in STK11 mutant NSCLC
2023 · Magnus Blø, Austin Rayford, et al. · Cancer Research
Optimizing immunoassay-based selection of donors for COVID-19 convalescent plasma
2021 · Hanora A Van Ert, Kai Rogers, et al. · The Journal of Immunology
Phosphatidylserine Receptor Enhancement of SARS-CoV-2 Entry: AXL as a Therapeutic Target for COVID-19
2021 · Dana Bohan, Hanora Van Ert, et al. · The Journal of Immunology
Works count: 11
Citation count: 179
H-index: 3
I10-index: 2
Year
Topic
Type